This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Press ReleasesIn the MediaAwardsScientific PublicationsRelated LinksSubscription Press MailingMedia Contact

Press Archive - Page 5 of 6


Mit der Unterstützung der Initiative „Diversity als Chance – die Charta der Vielfalt der Unternehmen in Deutschland“ setzt ITM Isotopen Technologien…

Read more

Endocyte, Inc., and ITM Isotopen Technologien München AG (ITM) today announced a supply agreement under which ITM will supply to Endocyte the medical…

Read more

First Patient enrolled in Europe for the clinical study COMPETE at the University Hospital Marburg, Germany.

COMPETE to investigate a broad…

Read more

ITM’s subsidiary ITM Solucin lead 2-day-event focused on study update and efficient trial execution.

Meeting attended by over 60 investigators as…

Read more

With a 174 % growth, ITM Isotopen Technologien München AG is one of the 50 winners of the Deloitte Technology Fast 50 Award 2017

Read more

Clinical development of Targeted Radionuclide Therapies to get major boost Investment will support growth initiatives of the company

Read more